Esomifor D 30mg/40mg Capsule SR is a combination medication containing Domperidone 30mg and Esomeprazole 40mg, formulated as a sustained-release capsule. Domperidone is a dopamine antagonist that enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms such as nausea and vomiting. Esomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing effective relief from acid-related disorders. This combination is primarily indicated for the management of gastroesophageal reflux disease (GERD), erosive esophagitis, and other acid-related gastrointestinal conditions where both acid suppression and improved gastric motility are desired. The sustained-release formulation ensures prolonged therapeutic effects, enhancing patient compliance by reducing dosing frequency. Esomifor D should be used under medical supervision, with caution in patients with known hypersensitivity to either component, and is contraindicated in those with prolactin-releasing pituitary tumors. Common adverse effects may include headache, dry mouth, abdominal discomfort, and dizziness. It is essential to follow prescribed dosages and consult a healthcare professional before initiating therapy to ensure safety and efficacy.